相关实验视频

Updated: May 31, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

分子过敏诊断使个性化医学成为可能

Paolo Maria Matricardi¹, Marianne van Hage², Adnan Custovic³

¹Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.

The Journal of allergy and clinical immunology

|January 24, 2025

概括

分子过敏诊断精确地绘制了个体IgE敏感化配置文件,在过敏学中推进了精准医学. 这种方法完善了过敏原特异性免疫疗法,并预测了过敏性疾病的严重程度.

科学领域:

过敏免疫学过敏免疫学
精准医学是一门精准的医学.
生物技术是生物技术.

背景情况:

过敏性疾病呈现出不同的表型,由患者特定的IgE敏感性配置驱动.
分子过敏诊断分析了分子过敏原水平的IgE活性,从而实现了个性化的治疗策略.

研究的目的:

突出分子过敏诊断在精准医学中的演变和影响.
为了强调重组过敏原在定义IgE反应性的有用性,以改善临床结果.

主要方法:

使用过敏原微阵列来评估复杂的IgE敏感化模式.
使用重组过敏原来定义精确的IgE反应性概况.
分析分子IgE敏感化模式,以预测疾病严重程度和表型.

主要成果:

已建立的分子IgE敏感化模式与严重的呼吸道和食物过敏相关.
确定了与对蜜蜂和虫的过敏相关的特定模式.
证明了分子诊断在区分协同和交叉敏感化的作用.

结论:

分子过敏诊断是个性化免疫疗法和避免过敏原的关键.
实施需要医学教育和决策支持系统,可能使用人工智能.
这种诊断方法将过敏学转变为精准医学.

关键词:

过敏过敏是一种过敏.过敏原是一种过敏原.过敏原免疫疗法免疫疗法过敏性鼻炎过敏性鼻炎喘喘是一种组件解决的诊断组件解决的诊断交叉反应性交叉反应性食物过敏食物过敏免疫球体蛋白E 免疫球体蛋白E 微阵列的微阵列分子过敏学分子过敏学泛过敏原是一种泛过敏原.精准医学是一门精准医学.毒液过敏是一种毒素过敏.

更多相关视频

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cross-reactivity

Cross-reactivity